Summary: Fragility fractures represent a growing problem with large economic and patient burdens that are likely to increase as the population ages. The elderly patient with osteopenic bone presents a unique surgical challenge with appreciable risks associated with each surgical treatment option. As demonstrated in this supplement, the current evidence suggests that the best surgical treatment options for patients with fragility fractures remains largely unknown. Additional evidence, from large clinical trials, is required before definitive treatment recommendations can be made in many cases. In this article, we review the example of the femoral neck fracture to illustrate this point.
INTRODUCTION
Despite years of investigation into the prevention and treatment of fragility fractures, controversy regarding the optimal medical and surgical treatments persists. As discussed in multiple articles within this supplement, large gaps in evidence exist in the diagnosis and treatment of fragility fractures. Although the questions that remain unanswered may vary across fracture types, we have used the femoral neck fracture in the current article as an example to demonstrate the current gap in definitive evidence. Recommended treatment options for femoral neck fractures have been based on fracture pattern, activity level, and chronologic age with less emphasis on bone quality and a lack of standardized patient subgroups in the randomized trials conducted to date. [1] [2] [3] [4] Commonly used treatment options include multiple methods of internal fixation, total joint replacement, and partial joint replacement.
Although multiple research initiatives have been successfully completed, they have produced conflicting results, and the definitive answer to the optimal treatment of femoral neck fractures remains elusive.
Does the Choice of Implant Impact Outcome of Internal Fixation?
Despite intensive investigation comparing internal fixation with arthroplasty, optimal approaches for internal fixation have largely been ignored. 5 Most of the trials comparing different internal fixation implants are derived from indirect comparisons of trials of arthroplasty versus internal fixation. Bhandari et al recently conducted a metaanalysis 1 that found a trend toward fewer fracture healing complications with sliding hip screws (SHS) when compared with three cancellous screws (odds ratio, 0.76; 95% confidence interval, 0.47-1.25). On the contrary, a prior meta-analysis by Parker et al, which included a review of 25 randomized controlled trials, found no significant difference in healing or complication rates among internal fixation techniques. A subsequent Cochrane Review 6 found increased operative time and blood loss with SHS but no significant differences in complications and healing. Several trials that have directly compared outcomes between SHS versus cancellous screws/pins in nondisplaced 7, 8 and displaced fractures 9-11 have demonstrated trends toward reduced revision rates with SHS. As a result of contradictory findings and methodological limitations, it can be argued that a definitive answer to the question of whether the choice of implant impacts the outcome of internal fixation remains unanswered. To address this important question, a large international randomized controlled trial called the Fixation using Alternative Implants for the Treatment of Hip Fractures (FAITH) has been initiated to assess key outcomes after standardized internal fixation techniques with either a SHS or cancellous screws. Internal fixation of displaced (Garden III and IV) femoral neck fractures has been associated with high rates of osteonecrosis and reoperation.
1 Several meta-analyses, 1, 13, 14 randomized controlled trials, [15] [16] [17] and prospective studies 18 comparing internal fixation with arthroplasty have been conducted. Bhandari et al 1 performed a meta-analysis of 14 randomized controlled trials assessing outcomes of surgery for displaced femoral neck fractures. This meta-analysis found that revision rates were significantly reduced with arthroplasty when compared with internal fixation (relative risk, 0.23; 95% confidence interval, 0.13-0.42), but there were trends toward increased mortality (relative risk, 1.27; 95% confidence interval, 0.84-1.92) and significant increases in blood loss and infection after arthroplasty. Dai et al also recently conducted a meta-analysis that compared internal fixation with arthroplasty in cognitively intact, mobile, elderly patients.
14 This meta-analysis found lower reoperation and complication rates after arthroplasty compared with internal fixation but also found a trend toward greater mortality at 1 year. Another meta-analysis by Rogmark et al 13 reported similar results as Dai et al with a trend toward greater mortality at 30 days but not at 1 year postsurgery. Discrepancies between these meta-analyses indicate that it is not known whether the optimal treatment is arthroplasty or internal fixation.
Additional large multicenter trials are necessary before a definitive treatment recommendation can be made.
Does Arthroplasty Type Impact Outcome?
Total hip arthroplasty (THA) 19 and hemiarthroplasty (HA) 20 have both been shown to be viable options in the treatment of displaced femoral neck fractures. Initial studies raised concerns over high rates of dislocation, 21 loosening, 22 and medical complications 23, 24 in THA and acetabular wear 25 after HA in high-demand patients. These studies shaped surgeons' initial reluctance toward concurrent acetabular replacement. 26 However, advancements in THA, particularly larger femoral head size and uncemented femoral components, 28 performed a metaanalysis comparing THA with HA (unipolar and bipolar), which included seven randomized controlled trials, three quasirandomized trials, and eight retrospective cohort studies. This study reported reduced reoperation rates and better functional improvements after THA than HA. Notably, their pooled analyses of four recent randomized controlled trials 2, 26, 27, 29 with the highest methodological quality suggested no significant impact of type of arthroplasty on reoperation rates and showed trends favoring HA for dislocations, deep infections, and general complications. Among two of the studies that reported functional outcomes, 26, 27, 29 functional gains with THA were superior. Unfortunately, this analysis encountered methodological issues such as lack of concealment, heterogeneity of study inclusion criteria, and type of HA. The difficulties incurred by pooling available evidence support the need for large, valid trials of high methodological quality. Currently, the HEALTH trial (Hip Fracture Evaluation with Alternatives of THA versus HA), an international multicenter randomized controlled trial comparing THA and HA in elderly patients with displaced femoral neck fractures, is underway to provide meaningful data on the optimal treatment for patients with displaced femoral neck fractures. 12 What Is the Role of Osteobiologics in the Treatment of Femoral Neck Fractures?
Osteobiologics are materials or agents that may promote fracture healing and enhance fracture stability. Given the challenges presented by femoral neck fragility fractures, osteobiologics may provide some benefit. Unfortunately, there has been limited clinical research conducted to date of the efficacy of osteobiologics and the treatment of femoral neck fractures. 30 Different osteobiologics have been developed and investigated, including allograft bone, calcium phosphate cement, osteoinductive growth factors (bone morphogenic proteins and platelet derived growth factors) and systemic agents such as parathyroid hormone. Basic science research on osteobiologics has shown promising results; however, few clinical trials have been conducted and the results of the trials conducted to date have been contradictory and inconclusive. 30 Additional clinical trials are required before clinical recommendations can be made on the efficacy of osteobiologics in patients with femoral neck fractures.
CONCLUSIONS
Despite being among the most common and debilitating orthopaedic injuries, optimal treatment for fragility femoral neck fractures remains elusive. As described, many patientimportant questions remain unanswered in the treatment of femoral neck fractures. Fortunately, multiple high-quality research initiatives on the treatment of femoral neck fractures are ongoing (Table 1) . International multicenter trials will play a primary role in resolving current controversy and enabling evidence-based tailoring of surgical care for patients with fragility femoral neck fractures.
The questions and concerns raised in this article can easily be translated to other types of fragility fractures. The current evidence is inconclusive regarding the optimal treatment methods for fragility fractures in general. Similar methodological limitations also exist in the research conducted to date in this area as evident by the articles in this supplement. Multiple diagnostic, prognostic, and treatment questions remain unanswered. Additional high-quality clinical trials are necessary before definitive recommendations can be made and patient care improved. We are hopeful with additional large, international initiatives that many of the unanswered questions will become known in the years to come.
